Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Host Microbe ; 26(5): 591-600.e4, 2019 11 13.
Article in English | MEDLINE | ID: mdl-31668877

ABSTRACT

Maternal infection with Zika virus (ZIKV) can lead to microcephaly and other congenital abnormalities of the fetus. Although ZIKV vaccines that prevent or reduce viremia in non-pregnant mice have been described, a maternal vaccine that provides complete fetal protection would be desirable. Here, we show that adenovirus (Ad) vector-based ZIKV vaccines induce potent neutralizing antibodies that confer robust maternal and fetal protection against ZIKV challenge in pregnant, highly susceptible IFN-αßR-/- mice. Moreover, passive transfer of maternal antibodies from vaccinated dams protected pups against post-natal ZIKV challenge. These data suggest that Ad-based ZIKV vaccines may be able to provide protection in pregnant females against fetal ZIKV transmission in utero as well as in infants against ZIKV infection after birth.


Subject(s)
Antibodies, Neutralizing/blood , Immunity, Maternally-Acquired/immunology , Receptor, Interferon alpha-beta/genetics , Viral Vaccines/immunology , Zika Virus Infection/prevention & control , Zika Virus/immunology , Adenoviridae/genetics , Adenoviridae/immunology , Animals , Antibodies, Neutralizing/immunology , Antibodies, Viral/blood , Antibodies, Viral/immunology , Cell Line , Chlorocebus aethiops , Disease Models, Animal , Female , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Pregnancy , Vaccination , Vero Cells , Zika Virus Infection/immunology
2.
J Virol ; 88(11): 6243-54, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24648461

ABSTRACT

UNLABELLED: Prime-boost immunization regimens have proven efficacious at generating robust immune responses. However, whether the level of replication of the boosting antigen impacts the magnitude and protective efficacy of vaccine-elicited immune responses remains unclear. To evaluate this, we primed mice with replication-defective adenovirus vectors expressing the lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP), followed by boosting with either LCMV Armstrong, which is rapidly controlled, or LCMV CL-13, which leads to a more prolonged exposure to the boosting antigen. Although priming of naive mice with LCMV CL-13 normally results in T cell exhaustion and establishment of chronic infection, boosting with CL-13 resulted in potent recall CD8 T cell responses that were greater than those following boosting with LCMV Armstrong. Furthermore, following the CL-13 boost, a greater number of anamnestic CD8 T cells localized to the lymph nodes, exhibited granzyme B expression, and conferred improved protection against Listeria and vaccinia virus challenges compared with the Armstrong boost. Overall, our findings suggest that the replicative capacity of the boosting antigen influences the protective efficacy afforded by prime-boost vaccine regimens. These findings are relevant for optimizing vaccine candidates and suggest a benefit of robustly replicating vaccine vectors. IMPORTANCE: The development of optimal prime-boost vaccine regimens is a high priority for the vaccine development field. In this study, we compared two boosting antigens with different replicative capacities. Boosting with a more highly replicative vector resulted in augmented immune responses and improved protective efficacy.


Subject(s)
Immunity, Heterologous/immunology , Immunization, Secondary/methods , Viral Vaccines/immunology , Virus Replication/physiology , Adenoviridae , Animals , Antigens, Heterophile/immunology , CD8-Positive T-Lymphocytes/immunology , Female , Flow Cytometry , Genetic Vectors , Glycoproteins/metabolism , Kaplan-Meier Estimate , Listeria/immunology , Lymphocytic choriomeningitis virus/metabolism , Mice , Mice, Inbred C57BL , Statistics, Nonparametric , Vaccinia virus/immunology
3.
PLoS Pathog ; 8(11): e1002998, 2012.
Article in English | MEDLINE | ID: mdl-23133386

ABSTRACT

Segment 7 of influenza A virus produces up to four mRNAs. Unspliced transcripts encode M1, spliced mRNA2 encodes the M2 ion channel, while protein products from spliced mRNAs 3 and 4 have not previously been identified. The M2 protein plays important roles in virus entry and assembly, and is a target for antiviral drugs and vaccination. Surprisingly, M2 is not essential for virus replication in a laboratory setting, although its loss attenuates the virus. To better understand how IAV might replicate without M2, we studied the reversion mechanism of an M2-null virus. Serial passage of a virus lacking the mRNA2 splice donor site identified a single nucleotide pseudoreverting mutation, which restored growth in cell culture and virulence in mice by upregulating mRNA4 synthesis rather than by reinstating mRNA2 production. We show that mRNA4 encodes a novel M2-related protein (designated M42) with an antigenically distinct ectodomain that can functionally replace M2 despite showing clear differences in intracellular localisation, being largely retained in the Golgi compartment. We also show that the expression of two distinct ion channel proteins is not unique to laboratory-adapted viruses but, most notably, was also a feature of the 1983 North American outbreak of H5N2 highly pathogenic avian influenza virus. In identifying a 14th influenza A polypeptide, our data reinforce the unexpectedly high coding capacity of the viral genome and have implications for virus evolution, as well as for understanding the role of M2 in the virus life cycle.


Subject(s)
Alternative Splicing , Influenza A Virus, H5N2 Subtype/metabolism , RNA, Messenger/biosynthesis , RNA, Viral/biosynthesis , Viral Matrix Proteins/biosynthesis , Animals , Birds , Cell Line, Tumor , Disease Outbreaks , Dogs , Humans , Influenza A Virus, H5N2 Subtype/genetics , Influenza in Birds/epidemiology , Influenza in Birds/genetics , Influenza in Birds/metabolism , Influenza, Human/epidemiology , Influenza, Human/genetics , Influenza, Human/metabolism , Mice , Mice, Inbred BALB C , North America/epidemiology , RNA, Messenger/genetics , RNA, Viral/genetics , Viral Matrix Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...